Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04985721
Title A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects (IMPARP-HRD)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Peter MacCallum Cancer Centre, Australia

Advanced Solid Tumor


Pamiparib + Tislelizumab

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST